id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0776-0013,FDA,FDA-2021-D-0776,Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial; Guidance for Industry; Availability,Notice,Guidance,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,,2022-11-07T13:31:59Z,2022-24112,0,0,0900006485492c29
FDA-2021-D-0776-0014,FDA,FDA-2021-D-0776,Studying Multiple Versions CGT Products Early Phase Clinical Trial Final 2022,Other,Guidance,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,,2024-11-07T00:43:37Z,,1,0,0900006485493210